About Quantumcyte
Quantumcyte is a Healthcare company based in Sunnyvale (United States) founded in 2013 by Bidhan Chaudhuri and John Butler. Drug assay systems for cancer treatment are developed and provided. Quantumcyte has raised $1.3 million across 2 funding rounds from investors including IndieBio. Its chief executive, as recorded, is John Butler. Quantumcyte offers products and services including QCPRECISEâ„¢ Platform and Sample Processing Service. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include Reaction Biology, Kiyatec and PhenoVista; 2 of its 3 listed competitors have raised funding.
Company details
Quantumcyte was founded in 2013 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where drug assay systems for cancer treatment are developed. These systems support evaluation of therapeutic compounds in research settings. The company is led by co-founders John Butler as CEO and Bidhan Chaudhuri as CTO. Focus remains on advancing assay technologies for oncology applications within the U.S. market.
- Headquarters Sunnyvale, United States
- Founders Bidhan Chaudhuri, John Butler
- SectorsHealthcare
- Website quantumcyte.com
- Social LinkedIn X YouTube
- Total Equity Funding$1.3M (USD)
in 2 rounds
- Latest Funding Round$1.05M (USD), Seed
Aug 2023
- Investors
Products & Services of Quantumcyte
Quantumcyte offers a comprehensive portfolio of products and services, including QCPRECISE™ Platform and Sample Processing Service.
Increases nucleic acid purity from biopsies for reliable multi-omic applications.
Handles tissue samples to deliver purified DNA or RNA for genomics.
Apps and channels of Quantumcyte
its YouTube channel QuantumCyte Biotech has 13 subscribers.
Funding Insights of Quantumcyte
Quantumcyte has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.05 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.3M
- Total Rounds 2
- Last Round Seed — $1.05M
- First Round $250,000
(May 2017)
- Investors Count 1
All 2 funding rounds of Quantumcyte with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $1.05M | Seed | – | – | – |
| May 2017 | $250,000 | Seed | – | IndieBio | – |
1 investors in total: 1 institutional.
Investors in Quantumcyte
Quantumcyte has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States |
Investor details for Quantumcyte
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Quantumcyte
4 people are tracked at Quantumcyte (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Bidhan Chaudhuri | Co-Founder & CTO | Leadership |
John Butler | Co-Founder & CEO | Leadership |
Bernadine Lim | Chief Commercial Officer (CCO) | Leadership |
Surekha Karudapuram | Product Management And Marketing Consultant | Team |
Complete people profiles for Quantumcyte
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Quantumcyte
3 dated milestones of Quantumcyte across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Quantumcyte is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Seed, of $1.1M.
Competitors of Quantumcyte
Quantumcyte has 3 listed competitors in our database, 2 of them funded. They include Reaction Biology, Kiyatec and PhenoVista.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| reactionbiology.com | 2001 | United States | 77 | In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling | ||
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| phenovista.com | 2014 | San Diego, United States | $3M | 11 | A CRO that provides phenotypic assay development and screening services. |
Detailed competitors of Quantumcyte
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Quantumcyte (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Quantumcyte
Quantumcyte was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Quantumcyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
John Butler is the CEO of Quantumcyte, as recorded in our data. They have also founded this company.
Quantumcyte is a funded company, having raised a total of $1.3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on May 2017.
Quantumcyte was founded in 2013 and is headquartered in Sunnyvale, United States. Operations are centered in the biotechnology sector, where drug assay systems for cancer treatment are developed. These systems support evaluation of therapeutic compounds in research settings. The company is led by co-founders John Butler as CEO and Bidhan Chaudhuri as CTO. Focus remains on advancing assay technologies for oncology applications within the U.S. market.
Quantumcyte's top competitors include Kiyatec, Reaction Biology and PhenoVista.
Quantumcyte offers QCPRECISEâ„¢ Platform and Sample Processing Service.
Quantumcyte has 1 investor. Key investors include IndieBio.